Skip to main content

Medtronic accused of 'repeatedly failing' to fix issues with implantable pump


Medtronic will stop making an implantable pump system, after federal regulators claimed the company failed to fix problems with its manufacturing.

In a deal announced Monday, the Food and Drug Administration said Medtronic was warned three times about "major violations" regarding the manufacturing of its Synchromed II Implantable Infusion Pump Systems from 2006 to 2013.

The FDA cited Medtronic for "repeatedly failing to correct" those violations, including:

  • Not having a process for identifying and correcting problems with the device
  • Failing to record needed design changes
  • Not ensuring the final product met design specifications

The pump device is implanted, and used to send medicine directly to the fluid around the spinal cord, Reuters says. It's used to treat patients with cancer, chronic pain and other issues.

According to the Star Tribune, Medtronic says 14 people have died as a result of complications with the device.

The FDA says the device would sometimes deliver too much or not enough of the medication, or can deliver the treatment later than intended.

Under the agreement – which is called a consent decree – the only time one of the pump systems can be manufactured and issued is if a doctor deems it "medically necessary" for a patient's treatment, the FDA says.

"We take our responsibility to ensure continued support for clinicians and their patients who rely on this important treatment option very seriously, and we are committed to working collaboratively with the FDA to address their expectations as quickly as possible," said Julie Foster, who works in Medtronic's Neuromodulation business.

In the meantime, Medtronic has to hire a third-party expert to help address those purported violations, and after some time could get the FDA's permission to once again manufacture the pump.

The devices aren't being recalled, but the FDA says anyone with a Synchromed II Implantable Infusion Pump System should maintain regular appointments with their doctor. If there is a change or return of symptoms, or if a device alarm going, they should contact their physician right away.

The Star Tribune says the company doesn't admit any fault or wrongdoing by agreeing to the terms.

A judge still has to give final approval to the deal.

Next Up

D'Angelo Russell

D'Lo's late takeover helps Timberwolves win double-OT thriller

Russell caught fire to help the Timberwolves get back to .500.

Gopher Football

Gophers suffocate Badgers, reclaim Paul Bunyan's Axe

Minnesota picked up its first home win over the Badgers since 2003.

Meeker County Sheriff's Office

Boy, 6, run over after falling off trailer in Meeker Co. tree farm accident

He was airlifted to Hennepin County Medical Center with internal injuries.

Target store

Target unveils deals for 2-day 'Cyber Monday' event

The promotion kicks off Sunday, November 28.

Screen Shot 2021-11-27 at 9.59.30 AM

Edina police warn of recent burglary trend targeting garages and vehicles

The Edina Police Department is increasing patrols in affected neighborhoods in response to the trend.

Screen Shot 2021-11-27 at 9.03.06 AM

Charges: Man shot Uber Eats driver making a delivery in Cottage Grove

Otis Donnell Shipp was charged with second-degree attempted murder after turning himself in on Wednesday.

Screen Shot 2021-11-27 at 7.36.14 AM

Waterfront hotel in Duluth sustains damage in kitchen fire

Authorities estimate the damage at around $75,000.

Screen Shot 2021-11-27 at 7.15.18 AM

Large groups of thieves target 2 Twin Cities Best Buys on Black Friday

It bears similarities to the flash-mob style thefts seen recently in California.

Karl-Anthony Towns

Timberwolves' winning streak snapped at five games

The Wolves' bid for their longest winning streak since 2014 came up short.

Screen Shot 2020-08-14 at 6.45.53 PM

Teen arrested over fatal shooting of 5-year-old boy in Brooklyn Park

Police say the teen was filming a social media video while handling a gun.

Joe Biden

President Biden coming to Minnesota to promote Bipartisan Infrastructure Law

Tuesday's trip follows passage of the $1.2 trillion Bipartisan Infrastructure Deal.


Medtronic seeks partner in brain pump project

Fridley-based Medtronic is looking for pharmaceutical industry partners as it seeks to advance a pump technology, which Medtronic believes could be a good delivery system for Alzheimer's medicines pushed directly into the brain, the Pioneer Press reports.